2017
DOI: 10.1016/j.nucmedbio.2017.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of a novel radiotracer for positron emission tomography imaging of reactive oxygen species in the central nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
19
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 26 publications
0
19
0
Order By: Relevance
“…20 A number of radiolabeled analogues of dihydro-methidium (also known as hydromethidine) have been synthesized and evaluated in vitro and in vivo, including [ 3 H]hydromethidine and [ 11 C]hydromethidine. 21,22 [ 3 H]Hydromethidine is oxidized by superoxide and hydroxyl radicals and has been evaluated in animal models of stroke and cisplatin-induced nephrotoxicity. 23,24 A recent paper on the radiosynthesis and preliminary in vivo evaluation of [ 11 C]methidium has also been reported.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…20 A number of radiolabeled analogues of dihydro-methidium (also known as hydromethidine) have been synthesized and evaluated in vitro and in vivo, including [ 3 H]hydromethidine and [ 11 C]hydromethidine. 21,22 [ 3 H]Hydromethidine is oxidized by superoxide and hydroxyl radicals and has been evaluated in animal models of stroke and cisplatin-induced nephrotoxicity. 23,24 A recent paper on the radiosynthesis and preliminary in vivo evaluation of [ 11 C]methidium has also been reported.…”
Section: Discussionmentioning
confidence: 99%
“…23,24 A recent paper on the radiosynthesis and preliminary in vivo evaluation of [ 11 C]methidium has also been reported. 22 It should also be noted that our group reported the in vitro properties of methidium toward various forms of ROS in the patent literature (U.S. Patent 9,035,057) but did not pursue radiolabeling of this compound because of our interest in developing an 18 F-labeled radiotracer for imaging ROS.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, there are only very few reports on PET tracers that could be used to specifically image ROS species in vivo. There are some studies concerned with the development of 18 F‐ and 11 C‐labelled dihydrophenantridine derivatives, which bind in their oxidised form to DNA in cells and become trapped, whereas the nonoxidised form is rapidly cleared from the cells. These studies are promising, because the tracers showed ROS‐specific uptake in vitro and in vivo using an animal model of neuroinflammation.…”
Section: Introductionmentioning
confidence: 99%
“…A number of radiolabeled analogs of dihydromethidium (a.k.a. hydromethidine), which is the corresponding N -methyl analog of DHE, have been synthesized and evaluated in vitro and in vivo [ 56 , 57 ]. [ 3 H]Dihydromethidium is oxidized by both superoxide and hydroxyl radicals and has been evaluated in animal models of stroke and cisplatin-induced nephrotoxicity [ 58 , 59 ].…”
Section: Pet Radiotracers For Imaging Rosmentioning
confidence: 99%
“…[ 3 H]Dihydromethidium is oxidized by both superoxide and hydroxyl radicals and has been evaluated in animal models of stroke and cisplatin-induced nephrotoxicity [ 58 , 59 ]. A recent paper has also reported the radiosynthesis and preliminary in vivo evaluation of [ 11 C]dihydromethidium [ 57 ]. This compound shows high brain uptake in microPET imaging studies, but a detailed analysis of the mechanisms of uptake and trapping of this radiotracer was not conducted.…”
Section: Pet Radiotracers For Imaging Rosmentioning
confidence: 99%